Yadanzioside P is primarily studied for its potential anti-cancer properties, particularly in the context of liver and lung cancer cells. It has demonstrated the ability to induce apoptosis and inhibit cell proliferation in vitro, making it a compound of interest in oncology research. Additionally, it shows anti-inflammatory effects by modulating key signaling pathways such as NF-κB, suggesting possible use in treating chronic inflammatory conditions. Its role in enhancing the sensitivity of cancer cells to conventional chemotherapeutic agents is also under investigation, which may support its future application in combination therapies. Due to its natural origin and bioactivity, it serves as a lead compound in the development of novel therapeutic agents.